2022-11-10 | OTCPK:ETST | Press release

0

Miami, Fla., Nov. 10, 2022 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “” Company”, a portfolio entity intended to acquire companies in the field of health and wellness currently in pharmaceutical compounding and telemedicine through its wholly-owned subsidiaries, today announced that the Company will report financial results for its second quarter of fiscal 2023 ended September 30, 2022 on November 14, 2022 at 4:00 p.m. EST.

Updated conference call and Webcast:

The company will host a conference call and webcast to discuss its fiscal second quarter results, highlights and outlook at 5:00 p.m. Eastern Time. To join the conference call, please dial the number at least 15 minutes before the start time.

Login information for attendees only:
Toll-free number for participants: 800-267-6316 Primary
Direct/international participant: 203-518-9783 Alternate
Conference ID: EARTH SCIENCE

For those unable to join, please email your questions to, [email protected]. The conference call will be recorded and accessible on the Investor Relations tab of the Company’s website.

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. (“ETST””) a holding entity that is to acquire companies in the health and wellness field currently in the preparation of pharmaceutical and telemedicine products through its wholly owned subsidiaries RxCompoundStore.com, LLC. and Peaks Curative, LLC.

To learn more, please visit: www.EarthScienceTech.com

About RxCompoundStore.com, LLC.

RxCompoundStore.com, LLC. (“RxCompound & CloseCurlyDoubleQuote;), is a compounding pharmacy that has historically focused on men’s health, particularly erectile dysfunction medical products such as Tadalfil and Sildenafil Citrate (the generic names of Cialis and Viagra, respectively) and longevity.

To learn more, please visit: www.RxCompoundStore.com

About Peaks Curative, LLC.

Healing Peaks, LLC. (“Peaks”), is the go-to telemedicine site facilitating asynchronous consultations for brand-name compound drugs compounded at RxCompound. Peaks is in the final stages of upgrading its website after its soft launch and increasing its product offering. Full launch of Peaks is scheduled for January 2023.

To learn more, please visit: www.PeaksCurative.com

SECURE DOOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial condition, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, management plans and objectives for our future operations, our CSE listing, including words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “could”, “should”, “will” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance or achievements differ materially from anticipated results, performance or achievements. We are under no obligation (and expressly disclaim any such obligation) to update or change our forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:

www.EarthScienceTech.com

Nickolas S. Tabraue

CEO and Director

[email protected]

786.375.7281

main logo

Share.

Comments are closed.